258
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Hyperbaric Oxygen Therapy Combined with Immunosuppression for Acute Macular Neuroretinopathy in Systemic Lupus Erythematosus

, MS, FRCS, , MS, FRCS, , DO, DNB, , MD, DMM & , MS, FRCOphth
Pages 355-361 | Received 29 Mar 2021, Accepted 10 Jan 2022, Published online: 03 Feb 2022

References

  • Bos PJ, Deutman AF. Acute macular neuroretinopathy. Am J Ophthalmol. 1975;80(4):573e84. doi:10.1016/0002-9394(75)90387-6.
  • Fawzi AA, Pappuru RR, Sarraf D, et al. Acute macular neuroretinopathy: long-term insights revealed by multimodal imaging. Retina. 2012;32(8):1500–1513. doi:10.1097/IAE.0b013e318263d0c3.
  • Aringer M, Costenbader K, Daikh D, et al. 2019 European league against rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151–1159. doi:10.1136/annrheumdis-2018-214819.
  • Bhavsar KV, Lin S, Rahimy E, et al. Acute macular neuroretinopathy: a comprehensive review of the literature. Surv Ophthalmol. 2016;61(5):538–565. doi:10.1016/j.survophthal.2016.03.003.
  • Arevalo JF, Lowder CY, Muci-Mendoza R. Ocular manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol. 2002;13(6):404–410. doi:10.1097/00055735-200212000-00011.
  • Lee DH, Lee SC, Kim M. Acute macular neuroretinopathy associated with systemic lupus erythematosus. Lupus. 2016;25(4):431–435. doi:10.1177/0961203315619494.
  • Haddad HM, Leopold IH. Effect of hyperbaric oxygenation on microcirculation: use in therapy of retinal vascular disorders. Invest Opthalmol. 1965;4(6):1141–1149.
  • Turbeville SD, Cowan LD, Gass JD. Acute macular neuroretinopathy: areview of the literature. Surv Opthalmol. 2003;48:1–11.
  • Vessey MP, Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. Br Med J. 1969;2:651–657.
  • Azar G, Wolff B, Cornut PL, et al. Spectral domain optical coherence tomography evolutive features in acute macular neuroretinopathy. Eur J Ophthalmol. 2012;22(5):850e2. doi:10.5301/ejo.5000172.
  • Regatieri CVS, Roh S, Weiter JJ. Retinal and choroidal circulation. In: Yanoff M, Duker JS, eds. Ophthalmology. Philadelphia: Elsevier Saunders; 2014:426–429.
  • Rahimy E, Sarraf D. Paracentral acute middle maculopathy spectral-domain optical coherence tomography feature of deep capillary ischemia. Curr Opin Ophthalmol. 2014;25(3):207–212. doi:10.1097/ICU.0000000000000045.
  • Rahimy E, Kuehlewein L, Sadda S, et al. Paracentral acute middle maculopathy: what we knew then and what we know now. Retina. 2015;35(10):1921–1930. doi:10.1097/IAE.0000000000000785.
  • Rait JL, O’Day J. Acute macular neuroretinopathy. Aust N Z J Ophthalmol. 1987;15(4):337–340. doi:10.1111/j.1442-9071.1987.tb00093.x.
  • Lee SY, Cheng JL, Gehrs KM, et al. Choroidal features of acute macular neuroretinopathy via optical coherence tomography angiography and correlation with serial multimodal imaging. JAMA Ophthalmol. 2017;135(11):1177–1183. doi:10.1001/jamaophthalmol.2017.3790.
  • Chu S, Nesper PL, Soetikno BT, Bakri SJ, Fawzi AA. Projection-Resolved OCT angiography of microvascular changes in paracentral acute middle maculopathy and acute macular neuroretinopathy. Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):2913–2922. doi:10.1167/iovs.18-24112.
  • Kim SH, Cha YS, Lee Y, Kim H, Yoon IN. Successful treatment of central retinal artery occlusion using hyperbaric oxygen therapy. Clin Exp Emerg Med. 2018;5(4):278–281. doi:10.15441/ceem.17.271.
  • Soares A, Gomes NL, Mendonça L, Ferreira C. The efficacy of hyperbaric oxygen therapy in the treatment of central retinal artery occlusion. BMJ Case Rep. 2017;2017:220113.
  • Butler FK, Hagan C, Van Hoesen K, Murphy-Lavoie H. Management of central retinal artery occlusion following successful hyperbaric oxygen therapy: case report. Undersea Hyperb Med. 2018;45(1):101–107. doi:10.22462/01.02.2018.14.
  • Wu X, Chen S, Li S, et al. Oxygen therapy in patients with retinal artery occlusion: a meta-analysis. PLoS ONE. 2018;13(8):e0202154. doi:10.1371/journal.pone.0202154.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.